statistiche per ANGELI, PAOLO

Distribuzione geografica

Continente	#
NA - Nord America	22795
EU - Europa	2544
AS - Asia	2400
Continente sconosciuto - Info sul continente non disponibili	11
SA - Sud America	6
AF - Africa	2
OC - Oceania	2
Totale	27760

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	22781
CN - Cina	1790
IT - Italia	587
FI - Finlandia	555
VN - Vietnam	525
SE - Svezia	497
DE - Germania	439
UA - Ucraina	244
GB - Regno Unito	116
IN - India	48
TR - Turchia	29
FR - Francia	22
GR - Grecia	20
CA - Canada	12
DK - Danimarca	11
NL - Olanda	11
EU - Europa	9
RO - Romania	7
BG - Bulgaria	5
ES - Italia	5
RU - Federazione Russa	5
AR - Argentina	4
BE - Belgio	4
CH - Svizzera	3
MK - Macedonia	3
SI - Slovenia	3
A1 - ???statistics.table.value.countryCode.A1???	2
AU - Australia	2
IR - Iran	2
LK - Sri Lanka	2
PL - Polonia	2
PT - Portogallo	2
AT - Austria	1
BR - Brasile	1
BZ - Belize	1
CL - Cile	1
CZ - Repubblica Ceca	1
HU - Ungheria	1
MX - Messico	1
NG - Nigeria	1
PH - Filippine	1
PK - Pakistan	1
SC - Seychelles	1
TH - Thailandia	1
TW - Taiwan	1
Totale	27760

Salva come PNG Salva come JPEG

Città	#
Fairfield	5149
Woodbridge	3158
Houston	2550
Ann Arbor	2415
Ashburn	1810
Seattle	1799
Wilmington	1748
Cambridge	1689
Jacksonville	1172
Dong Ket	524
San Diego	487
Nanjing	378
Beijing	374
Padova	198
Guangzhou	158
Shenyang	149
Nanchang	123
Hebei	110
Changsha	76
Jiaxing	76
Tianjin	67
Dearborn	59
Jinan	44
Norwalk	44
Redwood City	33
Hefei	30
Yenibosna	28
Kunming	27
Falls Church	24
Ningbo	22
Zhengzhou	18
Munich	15
Rome	15
Bologna	13
Nürnberg	13
Hangzhou	12
Lanzhou	12
Haikou	11
Taizhou	11
Mestre	9
Salerno	9
Chicago	8
Cologno Monzese	8
Duncan	8
Fuzhou	8
Las Vegas	8
Shanghai	8
Torino	8
Redmond	6
Toronto	6
Auburn Hills	5
Cesa	5
Chongqing	5
Costa Mesa	5
Florence	5
Indiana	5
Lyngby	5
Milan	5
Sofia	5
Taiyuan	5
Wuhan	5
Aarhus	4
Baotou	4
Buenos Aires	4
North York	4
Pavia	4
San Mateo	4
Timisoara	4
Trieste	4
Udine	4
Atena Lucana	3
Chengdu	3
Dallas	3
Detroit	3
Gurgaon	3
Leawood	3
Los Angeles	3
Napoli	3
New York	3
Palermo	3
Phoenix	3
Quzhou	3
Shaoxing	3
Skopje	3
Trento	3
Treviso	3
Varese	3
Youngstown	3
Aprilia	2
Ardabil	2
Buffalo	2
Colombo	2
Desio	2
Easton	2
Fort Worth	2
Genova	2
Hanover	2
Lake Forest	2
Majadahonda	2
Miane	2
Totale	24896

Salva come PNG Salva come JPEG

Nome	#
The animal naming test: An easy tool for the assessment of hepatic encephalopathy	164
Abnormalities in the 24-hour Rhythm of Skin Temperature in Cirrhosis: Sleep-Wake and General Clinical Implications	137
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial	136
Model for end-stage liver disease-sodium and survival benefit in liver transplantation.	130
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats.	128
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial	121
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study	118
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis	117
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections	116
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation	114
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy	114
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation	112
The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability	111
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis	110
Changes in Accident & Emergency Visits and Return Visits in Relation to the Enforcement of Daylight Saving Time and Photoperiod	109
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience	108
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial	108
The survival benefit of liver transplantation in hepatocellular carcinoma patients	107
Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report	107
Detection of minimal hepatic encephalopathy: Normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study	106
Reply to: "Tools and tactics for improving diagnosis of hepatic encephalopathy"	106
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy	105
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation	105
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes	103
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites	103
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide	103
Sequential versus "ab initio' combined diuretic treatment of moderate ascites in cirrhotic patients: Final results of a randomized controlled multicenter clinical study	102
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation	102
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features	101
Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine	100
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria	99
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size	99
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study	98
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis	97
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study	97
High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient study	97
The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis	96
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation.	96
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation?	95
A patients' and caregivers' perspective on hepatic encephalopathy.	95
Clinical value of asterixis in 374 well-characterised patients with cirrhosis and varying degree of hepatic encephalopathy	95
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases	94
Between reality and the guidelines: A survey on perception, diagnosis and management of hepatic encephalopathy in 201 Italian specialist centres	93
Covert hepatic encephalopathy: agreement and predictive validity of different indices	92
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.	92
Reply	92
Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites	92
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis	91
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats	90
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference	90
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation.	89
Urinary Ethyl Glucuronide Improves the Detection of Alcohol Consumption In Liver Transplant Candidates and Recipients	89
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome	89
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis	89
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure	89
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.	88
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study	88
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study	88
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites	87
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies.	87
Meld-na and Survival Benefit In Liver Transplantation	87
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals.	87
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis	87
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY	86
Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection	86
Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis	86
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?	85
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure	85
Adjuvant mitotane treatment for adrenocortical carcinoma.	84
Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study	84
Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.	84
Mutation analysis of the ATP7B gene in a new group of Wilson's disease patients: Contribution to diagnosis.	84
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial.	84
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid?	84
An Abnormal Gene Expression of the beta-Adrenergic System Contributes to the Pathogenesis of Cardiomyopathy in Cirrhotic Rats	83
A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy	83
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure	83
What type of probiotic was used?	82
Positive cardiac inotropic effect of albumin infusion in rats with cirrhosis and ascites: Molecular mechanisms	82
New diagnostic criteria and management of acute kidney injury	82
Lack of consensus for usage of β-blockers in end-stage liver disease	82
Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites	82
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe	82
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation	82
Neurological complications after orthotopic liver transplantation	81
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study	81
Why and how to measure renal function in patients with liver disease	81
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology	81
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study	80
Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis	80
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation.	79
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy	79
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis	79
Il timing del trapianto di fegato: Child-Pugh o Mayo score?	78
Improving the inhibitory control task to detect minimal hepatic encephalopathy.	78
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis	77
Splenic impedance indices: a useful method to monitor patients after liver transplantation?	77
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy	77
Immune thrombocytopenic purpura and Kaposi’s sarcoma in a liver transplant recipient	77
POSITIVE CARDIAC INOTROPIC EFFECT OF ALBUMIN INFUSION IN RATS WITH CIRRHOSIS AND ASCITES: MOLECULAR MECHANISMS	77
Totale	9454

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	28096
article - articoli	23933
book - libri	124
conference - conferenze	0
curatela - curatele	0
other - altro	69
patent - brevetti	0
selected - selezionate	0
volume - volumi	370
Totale	52592

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2016/2017	354	0	0	0	0	0	0	0	0	0	0	96	258
2017/2018	3919	764	2170	53	132	20	211	29	54	36	13	408	29
2018/2019	3889	24	17	439	27	42	21	38	312	54	603	1227	1085
2019/2020	8182	1303	298	169	808	822	597	818	890	912	736	500	329
2020/2021	5831	262	479	254	392	189	395	236	527	704	652	698	1043
2021/2022	4984	158	1026	659	434	371	376	405	623	372	201	359	0
Totale													28096